Substance reference

Resveratrol

Other compounds EFSANIH ODS / IOM-DRI (NASEM) 1 product in Stacky

What the European Food Safety Authority and the United States National Institutes of Health have published about resveratrol intake, and what the catalogue records. Reference figures and citations only.

Stacky is an organisational tool, not a medical device. It does not provide medical advice, and nothing on this page says what resveratrol does. Talk to a doctor or pharmacist before starting, stopping or changing what you take.

Published intake references

Each figure is one authority’s published value, with the kind of figure and the people it applies to as that authority stated them. Where the EU and the US differ, both are shown and neither is averaged or converted. Only a tolerable upper intake level sets a ceiling. A recommended or adequate intake is context, not a limit.

European Union — EFSA

No upper limit established by this authority None established EFSA has established no Dietary Reference Value (PRI/AI) and no Tolerable Upper Intake Level for this substance. It is not a nutrient in EFSA's DRV or UL programme, which covers vitamins, essential minerals and macronutrients. EFSA →

United States — NIH ODS / IOM

No upper limit established by this authority None established The IOM/NASEM Dietary Reference Intakes process has established no RDA, AI or Tolerable Upper Intake Level for this substance. It is not covered by the DRI framework, which addresses vitamins, elements and macronutrients. NIH ODS / IOM-DRI (NASEM) →

“None established” means that authority examined resveratrol and set no figure. A substance for which Stacky holds no published reference has no row here, and no page.

Products in Stacky’s catalogue containing Resveratrol

1 product whose label declares resveratrol, listed by brand and drawn as the app draws them. Amounts are the manufacturer’s printed figures; Stacky has measured nothing and ranks nothing.

How it is recorded

What the app records so it can schedule a dose. None of it is advice.

Food: the app records resveratrol as taken with food.

Indexed studies

A study reaches this page only if its own title names Resveratrol or one of its recorded alternative names, and does not name a disease or clinical condition. The second rule removes papers that are about resveratrol; a title naming a condition beside a substance reads as a claim, and this page makes none. Titles are the studies’ own words, newest first. A study being listed is not a statement that resveratrol does what it set out to test. How this list is built →

TitleJournalYearReference
Resveratrol and Its Effects on the Vascular System. Int J Mol Sci 2019 PubMed 30934670

Showing 1 of the 5 papers indexed against resveratrol in Stacky.

About this page

Stacky is a supplement tracking app. It renders what you take and what published sources say about it; it does not tell you what to take. Every figure on this page names the authority that published it and links to that authority’s own page.

Not on this page: a dose of our own, a grade, a verdict on whether resveratrol works, or any statement that it treats, prevents or improves a condition. How these pages are built →

Figures are read from the authorities’ published tables and can go out of date when those tables are revised. If one here is wrong, tell us at support@stacky-app.com and we will check it against the source.